Related Experiment Video
Updated: Aug 15, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
[Impact of fluoroquinolone use on multidrug-resistant bacteria emergence]
S Nseir1, F Ader, C-H Marquette
1Service de Réanimation Médicale, Hôpital A. Calmette, CHRU de Lille, boulevard du Pr-Leclercq, 59037 Lille cedex, France. s-nseir@chru-lille.fr
Abstract:
During the last two decades, fluoroquinolone use has significantly increased in Europe and in the USA. This could be explained by the arrival of newer fluoroquinolones with antipneumoccal activity. Increased use of fluoroquinolones is associated with higher rates of bacterial resistance to these antibiotics. Resistance of Gram-negative bacilli to fluoroquinolones is increasing in industrialized countries. In addition, fluoroquinolone use has been identified as a risk factor for colonization and infection to methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumanni, extending-spectrum beta-lactamase producing Gram negative bacilli, and multidrug-resistant bacteria. Nosocomial infections due to multidrug-resistant bacteria are associated with higher mortality and morbidity rates. This could be related to more frequent inappropriate initial antibiotic treatment in these patients. Limiting the use of fluoroquinolones, limiting the duration of treatment with fluoroquinolones, and using appropriate dosage of these antibiotics could be suggested to reduce resistance to these antibiotics and to reduce the emergence of multidrug-resistant bacteria.
Insights
Increased fluoroquinolone use correlates with rising antibiotic resistance, particularly in Gram-negative bacteria. Strategies like limiting use and duration can combat this growing public health threat.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Context:
- Fluoroquinolone antibiotic usage has substantially risen in Europe and the USA over the past 20 years.
- This increase is partly attributed to the introduction of newer fluoroquinolones with enhanced antipneumococcal activity.
- Rising fluoroquinolone consumption is linked to escalating rates of bacterial resistance to these drugs.
Purpose:
- To analyze the association between increased fluoroquinolone use and the development of antimicrobial resistance.
- To identify specific bacterial pathogens and resistance mechanisms linked to fluoroquinolone exposure.
- To explore strategies for mitigating fluoroquinolone resistance and the emergence of multidrug-resistant bacteria.
Summary:
- Fluoroquinolone resistance is increasing in Gram-negative bacilli in industrialized nations.
- Fluoroquinolone use is a risk factor for infections with resistant pathogens like MRSA, Pseudomonas aeruginosa, Acinetobacter baumannii, ESBL-producing Gram-negatives, and multidrug-resistant bacteria.
- Nosocomial infections caused by multidrug-resistant bacteria are associated with increased mortality and morbidity, potentially due to inappropriate initial antibiotic therapy.
Impact:
- Findings highlight the critical need for antimicrobial stewardship programs focused on fluoroquinolones.
- Recommendations include judicious fluoroquinolone prescribing, limiting treatment duration, and optimizing dosage to preserve antibiotic efficacy.
- Implementing these strategies can help reduce the incidence of fluoroquinolone resistance and the spread of multidrug-resistant organisms, thereby improving patient outcomes and reducing healthcare costs.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing